ADHD drugs linked to low bone density in kids

3 March 2016
lots-of-pills-big

Children and teenagers who take medication for attention-deficit hyperactivity disorder (ADHD) show decreased bone density, a study has found.

The American Academy of Orthopaedic Surgeons' (AAOS) annual meeting heard how researchers identified 5,315 pediatric patients and compared children who reported taking ADHD medications with survey participants not on these medications.

The results indicated that children on ADHD medication had lower bone mineral density in the femur, femoral neck and lumbar spine.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical